Sean F. Scanlan Treace Medical Concepts, Inc. (TMCI) insider trading activity

Sean F. Scanlan is Chief Innovation Officer of TREACE MEDICAL CONCEPTS, INC.. Currently has a direct ownership of 364,081 shares of TMCI, which is worth approximately $2.46 Million. The most recent transaction as insider was on Mar 02, 2022, when has been sold 25,000 shares (Common Stock) at a price of $1.05 per share, resulting in proceeds of $26,250. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 364K

61.63% 3M change

281.54% 12M change

Total Value Held $2.46 Million

Sean F. Scanlan Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 02 2022	BUY Exercise of conversion of derivative security	$26,250 $1.05 p/Share	25,000 Added 50.0%	25,000 Common Stock
Feb 09 2022	SELL Open market or private sale	$78,080 $20.16 p/Share	3,873 Reduced 100.0%	0 Common Stock
Feb 09 2022	BUY Exercise of conversion of derivative security	$4,067 $1.05 p/Share	3,873 Added 50.0%	3,873 Common Stock
Feb 08 2022	SELL Open market or private sale	$422,963 $20.02 p/Share	21,127 Reduced 100.0%	0 Common Stock
Feb 08 2022	BUY Exercise of conversion of derivative security	$22,183 $1.05 p/Share	21,127 Added 50.0%	21,127 Common Stock
Jan 11 2022	SELL Open market or private sale	$177,821 $20.12 p/Share	8,838 Reduced 100.0%	0 Common Stock
Jan 11 2022	BUY Exercise of conversion of derivative security	$11,578 $1.31 p/Share	8,838 Added 50.0%	8,838 Common Stock
Jan 10 2022	SELL Open market or private sale	$783,458 $20.16 p/Share	38,862 Reduced 100.0%	0 Common Stock
Jan 10 2022	BUY Exercise of conversion of derivative security	$61,013 $1.57 p/Share	38,862 Added 50.0%	38,862 Common Stock
Jan 05 2022	SELL Open market or private sale	$16,016 $20.02 p/Share	800 Reduced 100.0%	0 Common Stock
Jan 05 2022	BUY Exercise of conversion of derivative security	$1,256 $1.57 p/Share	800 Added 50.0%	800 Common Stock
Jan 04 2022	SELL Open market or private sale	$10,000 $20.0 p/Share	500 Reduced 100.0%	0 Common Stock
Jan 04 2022	BUY Exercise of conversion of derivative security	$785 $1.57 p/Share	500 Added 50.0%	500 Common Stock
Jan 03 2022	SELL Open market or private sale	$20,020 $20.02 p/Share	1,000 Reduced 100.0%	0 Common Stock
Jan 03 2022	BUY Exercise of conversion of derivative security	$1,570 $1.57 p/Share	1,000 Added 50.0%	1,000 Common Stock
Nov 10 2021	SELL Open market or private sale	$546,750 $21.87 p/Share	25,000 Reduced 100.0%	0 Common Stock
Nov 10 2021	BUY Exercise of conversion of derivative security	$39,250 $1.57 p/Share	25,000 Added 50.0%	25,000 Common Stock

SFS

Sean F. Scanlan

Chief Innovation Officer

Ponte Vedra, FL

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TMCI shares.

Notify only if

Value

Insider Trading

Get notified when an Treace Medical Concepts, Inc. insider buys or sells TMCI shares.

Notify only if

Operation

Value

Type

News

Receive news related to TREACE MEDICAL CONCEPTS, INC.

Track Activities on TMCI

Account